---
title: "Tilray Brands Inc. Stock Falls Tuesday, Underperforms Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286161168.md"
description: "Tilray Brands Inc. (TLRY) shares fell 1.81% to $5.41 on Tuesday, marking the fourth consecutive day of losses. The stock underperformed in a mixed trading session, with the Dow Jones up 0.11% and NASDAQ down 0.71%. Tilray's stock is currently 76.68% below its 52-week high of $23.20, reached on October 9th. Trading volume was 2.8 million, significantly below the 50-day average of 4.9 million."
datetime: "2026-05-12T21:30:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286161168.md)
  - [en](https://longbridge.com/en/news/286161168.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286161168.md)
---

# Tilray Brands Inc. Stock Falls Tuesday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Tilray Brands Inc. (TLRY) shed 1.81% to $5.41 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the NASDAQ Composite Index falling 0.71% to 26,088.20.

This was the stock's fourth consecutive day of losses.

Tilray Brands Inc. closed 76.68% short of its 52-week high of $23.20, which the company achieved on October 9th.

Trading volume (2.8 M) remained 2.1 million below its 50-day average volume of 4.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-12-26 1730ET

### Related Stocks

- [TLRY.US](https://longbridge.com/en/quote/TLRY.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Regenxbio's muscle disorder therapy meets main goal in late-stage study](https://longbridge.com/en/news/286406339.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)